Akari Therapeutics appoints Torsten Hombeck as CFO effective Dec 16, 2024

Akari Therapeutics Plc

Torsten Hombeck appointed CFO effective Dec 16, 2024; previously served as CFO from Oct 2019 to June 2024.
Annual base salary of $300,000 with target bonus of up to 100%.
Dr. Hombeck most recently served as CFO at Aspira Women's Health (June 2023–June 2024).
No family relationships or transactions with other directors or officers noted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.